Automated Patch Clamp System Market is Estimated to Witness High Growth Owing to Rising Prevalence of Neurological Disorders
Automated Patch Clamp System Market |
The
automated patch clamp system market has been gaining significant traction over
the past few years owing to the rising prevalence of various neurological
disorders such as epilepsy, Alzheimer’s disease and Parkinson’s disease.
Automated patch clamp systems are used to study ion channels and receptors
functions in excitable and non-excitable cells from various tissues like
neurons, cardiomyocytes and others. These systems provide high-quality data at
a much faster speed as compared to manual patch clamp instruments. The
automated technology also mitigates variability associated with manual
experiments and reduces experiment time significantly. The need for advanced
diagnostic techniques and drug discovery processes have also propelled the
demand for automated patch clamp systems across research institutes and
pharmaceutical companies.
The Global automated patch clamp system market is estimated to be valued at US$ 579.83 Mn in 2024 and is expected
to exhibit a CAGR of 6.0% over the
forecast period from 2024 to 2030.
Key Takeaways
Key players operating in the Automated
Patch Clamp System Market Size are GE Healthcare, Siemens Healthineers,
Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare,
Canon Medical Systems Corporation, Mindray Medical International Limited,
Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG,
Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International,
Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron
Corporation, Shimadzu Corporation, Trifoil Imaging.
The key opportunities in the market include development of advanced systems
with higher throughput, miniaturized systems and those integrated with novel
technologies. Growing focus on neuroscience research by pharmaceutical
companies as well as research institutes represent major growth opportunities.
With presence across Americas, Europe, Asia Pacific and Rest of the world, the
key players are focusing on expansion in emerging markets such as Asia Pacific
and Latin America through partnerships, mergers and acquisitions.
Market drivers
The major market driver is the rising cases of neurological disorders across
the globe. It has propelled the demand for timely and accurate diagnosis as
well as development of novel therapeutics. According to WHO, over 50 million
people suffered from epilepsy, 50 million have Alzheimer's disease and 6.2 million
have Parkinson's disease worldwide in 2019. With increasing geriatric
population, prevalence of such disorders is expected to grow rapidly in
upcoming years, augmenting the demand. Secondly, increasing R&D investments
in pharmaceutical and biotechnology sector have led to rising adoption of
automated patch clamp systems for drug screening and development.
PEST Analysis
Political: Government regulations regarding medical device approvals and
standards compliance. Patent protection and import-export laws impact
innovation and trade.
Economic: Funding availability from research grants and venture capital for
early/mid-stage companies impacts technology development. Reimbursement rates
determined by public and private payers affect market adoption.
Social: Growing aging population drives demand for diagnostic technologies.
Increased awareness of personalized medicine empowers patients to seek advanced
care options.
Technological: Advancements in automation, miniaturization, and data
integration enable high-throughput screening at single-cell resolution.
Cloud-based platforms support remote experimentation and collaborative
research.
North America holds the largest share of the automated patch clamp system
market, by value. The region's dominance can be attributed to the presence of
major players, rising emphasis on drug discovery research, growing prevalence
of chronic diseases, and availability of funding for life science research.
The Asia Pacific region is projected to grow at the fastest CAGR during the
forecast period. Factors such as increase in healthcare expenditure, rise in
the number of CROs and pharmaceutical companies, untapped opportunities in
emerging countries, and growing R&D investments from government and private
bodies are driving the automated patch clamp system market in the Asia Pacific
region.
Get
more insights on- Automated
Patch Clamp System Market
Comments
Post a Comment